| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.26 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |